norfloxacin has been researched along with Allergy, Drug in 6 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Excerpt | Relevance | Reference |
---|---|---|
"A 77-year-old male who had suffered from an upper respiratory infection and had been given Norfloxacin (NFLX) on May 2, 1990, developed generalized erythema which did not subside with prednisolone." | 7.68 | [Norfloxacin-induced infectious mononucleosis (IM)-like syndrome with Stevens-Johnson syndrome]. ( Kubo-Shimasaki, A; Tatsumi, E; Yamaguchi, N; Yoneda, N; Yoshimoto, K, 1992) |
" Norfloxacin has been incriminated previously as a cause once only, with acute interstitial nephritis (AIN) as the histopathological finding." | 4.79 | Allergic nephropathy associated with norfloxacin and ciprofloxacin therapy. Report of two cases and review of the literature. ( Almroth, G; Cederbrant, K; Eneström, S; Hadimeri, H; Hultman, P; Lindell, A, 1997) |
"To better understand how T cells interact with quinolones, we analysed six patients with delayed hypersensitivity reactions to ciprofloxacin (CPFX), norfloxacin (NRFX) or moxifloxacin (MXFX)." | 3.73 | T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. ( Depta, JP; Pichler, WJ; Schmid, DA, 2006) |
"A 77-year-old male who had suffered from an upper respiratory infection and had been given Norfloxacin (NFLX) on May 2, 1990, developed generalized erythema which did not subside with prednisolone." | 3.68 | [Norfloxacin-induced infectious mononucleosis (IM)-like syndrome with Stevens-Johnson syndrome]. ( Kubo-Shimasaki, A; Tatsumi, E; Yamaguchi, N; Yoneda, N; Yoshimoto, K, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Loli-Ausejo, D | 1 |
Vílchez-Sánchez, F | 1 |
Cabañas, R | 1 |
Fiandor, A | 1 |
Lluch-Bernal, M | 1 |
González-Muñoz, M | 1 |
Domínguez-Ortega, J | 1 |
Schmid, DA | 1 |
Depta, JP | 1 |
Pichler, WJ | 1 |
Hadimeri, H | 1 |
Almroth, G | 1 |
Cederbrant, K | 1 |
Eneström, S | 1 |
Hultman, P | 1 |
Lindell, A | 1 |
Postema, RR | 1 |
Ong, GL | 1 |
Bruining, HA | 1 |
Kubo-Shimasaki, A | 1 |
Yoshimoto, K | 1 |
Tatsumi, E | 1 |
Yoneda, N | 1 |
Yamaguchi, N | 1 |
Burks, EJ | 1 |
1 review available for norfloxacin and Allergy, Drug
Article | Year |
---|---|
Allergic nephropathy associated with norfloxacin and ciprofloxacin therapy. Report of two cases and review of the literature.
Topics: Aged; Anti-Infective Agents; Biopsy; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Kidney; N | 1997 |
5 other studies available for norfloxacin and Allergy, Drug
Article | Year |
---|---|
Basophil activation test in the diagnosis of hypersensitivity reactions to quinolones in a real-life setting.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Basophil Degranulation Test; Ciprofloxacin; D | 2021 |
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell | 2006 |
[Fever in intensive care: keep medications in mind at all times].
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Drug Hypersensit | 1998 |
[Norfloxacin-induced infectious mononucleosis (IM)-like syndrome with Stevens-Johnson syndrome].
Topics: Aged; Drug Hypersensitivity; Erythema; Fatigue Syndrome, Chronic; Humans; Male; Norfloxacin; Stevens | 1992 |
Norfloxacin hypersensitivity.
Topics: Adult; Drug Hypersensitivity; Female; Humans; Norfloxacin | 1989 |